Impact Factor 3.845 | CiteScore 3.92
More on impact ›

Clinical Trial ARTICLE Provisionally accepted The full-text will be published soon. Notify me

Front. Pharmacol. | doi: 10.3389/fphar.2019.01325

The Impact of Ayahuasca on Suicidality: Results from a Randomized Controlled Trial

  • 1Department of Psychology, Ryerson University, Canada
  • 2Division of Brain Sciences, Department of Medicine, Faculty of Medicine, Imperial College London, United Kingdom
  • 3Brain Institute, Federal University of Rio Grande do Norte, Brazil
  • 4Onofre Lopes University Hospital, Brazil
  • 5Department of Neurosciences and Behavioral Sciences, Medical School of Ribeirão Preto, University of São Paulo, Brazil

Suicide is a major public health problem. Given increasing suicide rates and limitations surrounding current interventions, there is an urgent need for innovative interventions for suicidality. Although ayahuasca has been shown to target mental health concerns associated with suicidality (i.e., depression and hopelessness), research has not yet explored the impact of ayahuasca on suicidality. Therefore, we conducted secondary analyses of a randomized placebo-controlled trial in which individuals with treatment-resistant depression were administered one dose of ayahuasca (n=14) or placebo (n=15). Suicidality was assessed by a trained psychiatrist at baseline, as well as 1 day, 2 days, and 7 days after the intervention. A fixed-effects linear mixed model, as well as between and within-groups Cohen’s d effect sizes were used to examine changes in suicidality. Controlling for baseline suicidality, we found a significant effect for time (p <.05). The effect of the intervention (i.e., ayahuasca vs. placebo) trended toward significance (p = .088). At all time points, we found medium between-group effect sizes (i.e., ayahuasca vs. placebo; day 1 Cohen’s d = 0.58; day 2 d = 0.56; day 7 d = 0.67), as well as large within-group (ayahuasca; day 1 Cohen’s d = 1.33; day 2 d = 1.42; day 7 d = 1.19) effect sizes, for decreases in suicidality. Conclusions: This research is the first to explore the impact of ayahuasca on suicidality. The findings suggest that ayahuasca may show potential as an intervention for suicidality. We highlight important limitations of the study, potential mechanisms, and future directions for research on ayahuasca as an intervention for suicidality.

Keywords: Suicidality, ayahuasca, psychedelics, randomized controlled trial, Novel intervention

Received: 24 Jul 2019; Accepted: 15 Oct 2019.

Copyright: © 2019 Zeifman, Palhano-Fontes, Hallak, Nunes, Maia-de-Oliveira and de Araujo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Dr. Draulio B. de Araujo, Brain Institute, Federal University of Rio Grande do Norte, Natal, 59056-450, Rio Grande do Norte, Brazil, draulio@neuro.ufrn.br